Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis
Kazuhiro Komura(Kanazawa University), Shinichi Sato(University of Tokyo Hospital), Takashi Hirano(Tokyo Medical University), Minoru Hasegawa(University of Fukui), Yasuhito Hamaguchi(Kanazawa University), Mayuka Horikawa(Kanazawa University), Takashi Matsushita(Kanazawa University), Kazuhiko Takehara(Kanazawa University), Miki Kondo(Kanazawa University), Manabu Fujimoto(Osaka Gakuin University), Kenzo Kaji(Kanazawa University), Hidemitsu Orito(Kanazawa University)
Cited by 57
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438